DrugPatentWatch Database Preview
Drugs in Development Information for Danirixin
Summary for Danirixin
| US Patents | 2 |
| International Patents | 45 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-04-28) |
| Vendors | 15 |
US Patents for Danirixin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Danirixin | ➤ Sign Up | IL-8 receptor antagonists | GlaxoSmithKline, LLC (Philadelphia, PA) | ➤ Sign Up |
| Danirixin | ➤ Sign Up | Hydrobromide salt of N-(4-chloro-2-hydroxy-3-((3S)-3-piperidinylsulfonyl)phenyl-N'-(3-fluoro-2- -methylphenyl)urea | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Danirixin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Danirixin | Argentina | 060562 | 2026-04-21 | ➤ Sign Up |
| Danirixin | Australia | 2007240365 | 2026-04-21 | ➤ Sign Up |
| Danirixin | Brazil | PI0710232 | 2026-04-21 | ➤ Sign Up |
| Danirixin | Canada | 2650009 | 2026-04-21 | ➤ Sign Up |
| Danirixin | Chile | 2007001142 | 2026-04-21 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
